Iterum Therapeutics Plc Stock
Iterum Therapeutics Plc Stock price
Key metrics
| Market capitalization | $54.76m |
| Enterprise Value | $62.96m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | negative |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-26.46m |
| Free Cash Flow (TTM) Free Cash Flow | $-35.21m |
| Cash position | $14.50m |
Is Iterum Therapeutics Plc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
Iterum Therapeutics Plc Stock Analysis
Analyst Opinions
2 Analysts have issued a Iterum Therapeutics Plc forecast:
Analyst Opinions
2 Analysts have issued a Iterum Therapeutics Plc forecast:
Financial data from Iterum Therapeutics Plc
| Sep '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.46 -0.46 |
74%
74%
|
|
| EBITDA | -26 -26 |
38%
38%
|
EBIT (Operating Income) EBIT | -26 -26 |
40%
40%
|
| Net Profit | -31 -31 |
2%
2%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Iterum Therapeutics Plc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Iterum Therapeutics Plc Stock News
Company Profile
Iterum Therapeutics Plc is a pharmaceutical company which engages in the development and commercialization of sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available. Sulopenem is a potent, thiopenem antibiotic delivered intravenously which is active against bacteria that belong to the group of organisms known as gram-negatives and cause urinary tract and intra-abdominal infections. It operates through the Ireland and Unites States geographical segments. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.
| Head office | Ireland |
| CEO | Corey Fishman |
| Employees | 14 |
| Founded | 2015 |
| Website | www.iterumtx.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
